Content about Ernst & Young

January 7, 2013
Ernst & Young report forecasts more difficult M&A environment for pharma companies

While pressure to grow will drive more large drug makers to pursue mergers and acquisitions, diminished resources and competition from biotech and specialty pharmaceutical companies will challenge their ability to do so, according to a new report.

SAN FRANCISCO — While pressure to grow will drive more large drug makers to pursue mergers and acquisitions, diminished resources and competition from biotech and specialty pharmaceutical companies will challenge their ability to do so, according to a new report.

November 15, 2012
Lupin CEO wins Ernst & Young award

The head of Lupin Pharmaceuticals has received an award from accounting firm Ernst & Young.

BALTIMORE — The head of Lupin Pharmaceuticals has received an award from accounting firm Ernst & Young.

Ernst & Young announced Thursday that it had named Lupin CEO Vinita Gupta the inaugural Ernst & Young U.S. 2012 Family Business Award of Excellence winner at its 2012 Strategic Growth Forum in Palm Springs, Calif.

April 11, 2012
Walgreens adds seasoned technology, sustainability vet to board

Walgreens on Tuesday evening elected Jan Babiak, a retired managing partner for Ernst & Young, to its board of directors.

DEERFIELD, Ill. — Walgreens on Tuesday evening elected Jan Babiak, a retired managing partner for Ernst & Young, to its board of directors. Babiak, who joins the board as an independent director, becomes the board’s 12th member.

July 5, 2011
Amneal's president, CEO win Ernst & Young Entrepreneur of the Year award

Chirag Patel and Chintu Patel, who respectively are the president and CEO of Amneal Pharmaceuticals, recently received the Ernst & Young Entrepreneur of the Year award.

BRIDGEWATER, N.J. — Chirag Patel and Chintu Patel, who respectively are the president and CEO of Amneal Pharmaceuticals, recently received the Ernst & Young Entrepreneur of the Year award.

The executives received the 2011 New Jersey Award in the pharmaceutical and medical technology category, which was presented at a gala event last month.

June 10, 2010
Diplomat CEO receives award from Ernst & Young

Diplomat Specialty Pharmacy on Friday announced Diplomat president and CEO Phil Hagerman was named Ernst...